Skip to content

Advertisement

BMC Infectious Diseases

What do you think about BMC? Take part in

HIV and co-infections

Section edited by Carlo Torti and Andrea De Luca

This section aims to publish studies looking at all aspects of the prevention, diagnosis and management of HIV and HIV-associated infections in humans, as well as related molecular genetics, pathophysiology, and epidemiology. This section also aims to publish studies on the adverse events of HAART and non HIV-related comorbidities in the HAART era.

Previous Page Page 1 of 23 Next Page
  1. Content type: Research article

    The HIV-1 DNA reservoir is an important marker that reflects viro-immunological status and can be affected by multiple viral or cellular factors. Determining the potential factors associated with the size of t...

    Authors: Yongsong Yue, Nidan Wang, Yang Han, Ting Zhu, Jing Xie, Zhifeng Qiu, Xiaojing Song, Yanling Li, Jean-Pierre Routy, Jianhua Wang and Taisheng Li

    Citation: BMC Infectious Diseases 2017 17:771

    Published on:

  2. Content type: Research article

    The outbreak of the Ebola virus disease (EVD) in 2014 led to massive dropouts in HIV care in Guinea. Meanwhile, Médecins Sans Frontières (MSF) was implementing a six-monthly appointment spacing approach adapte...

    Authors: Cavin Epie Bekolo, Abdourahimi Diallo, Mit Philips, Joseph-Desire Yuma, Letizia Di Stefano, Stéphanie Drèze, Jerome Mouton, Youssouf Koita and Ousseni W. Tiomtore

    Citation: BMC Infectious Diseases 2017 17:766

    Published on:

  3. Content type: Research article

    According to World Health Organization (WHO) guidelines, which have also been adopted by the National AIDS Control Organization (NACO), India, Efavirenz-based Anti-Retroviral Therapy (ART) is better in Human-I...

    Authors: Sanjeev Sinha, Kartik Gupta, Srikanth Tripathy, Sahajal Dhooria, Sanjay Ranjan and R. M. Pandey

    Citation: BMC Infectious Diseases 2017 17:761

    Published on:

  4. Content type: Research article

    There is today no gold standard method to accurately define the time passed since infection at HIV diagnosis. Infection timing and incidence measurement is however essential to better monitor the dynamics of l...

    Authors: Chris Verhofstede, Katrien Fransen, Annelies Van Den Heuvel, Kristel Van Laethem, Jean Ruelle, Ellen Vancutsem, Karolien Stoffels, Sigi Van den Wijngaert, Marie-Luce Delforge, Dolores Vaira, Laura Hebberecht, Marlies Schauvliege, Virginie Mortier, Kenny Dauwe and Steven Callens

    Citation: BMC Infectious Diseases 2017 17:738

    Published on:

  5. Content type: Research article

    Before Pre-Exposure Prophylaxis (PrEP) was officially recommended and made available, a few surveys among gay and bisexual men, and persons living with HIV/AIDS (PLWHA), identified an informal use of antiretro...

    Authors: Antonio Palummieri, Gabriella De Carli, Éric Rosenthal, Patrice Cacoub, Cristina Mussini and Vincenzo Puro

    Citation: BMC Infectious Diseases 2017 17:734

    Published on:

  6. Content type: Research article

    Knowledge of HIV status can be important in reducing the risk of HIV exposure. In a European sample of men-who-have-sex-with-men (MSM), we aimed to identify factors associated with HIV serostatus disclosure to...

    Authors: Ulrich Marcus, Susanne Barbara Schink, Nigel Sherriff, Anna-Marie Jones, Lorenzo Gios, Cinta Folch, Torsten Berglund, Christiana Nöstlinger, Marta Niedźwiedzka-Stadnik, Sonia F. Dias, Ana F. Gama, Emilia Naseva, Ivailo Alexiev, Danica Staneková, Igor Toskin, Daniela Pitigoi…

    Citation: BMC Infectious Diseases 2017 17:730

    Published on:

  7. Content type: Research article

    Switch strategies based on rilpivirine/tenofovir/emtricitabine or on an integrase inhibitor (InSTI) plus tenofovir/emtricitabine have never been compared in randomized clinical trials. The main aim of the stud...

    Authors: Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin and Antonella Castagna

    Citation: BMC Infectious Diseases 2017 17:723

    Published on:

  8. Content type: Research article

    There is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease. It is unclear how the risk varies as exposure accumulates.

    Authors: Kunchok Dorjee, Sanjiv M. Baxi, Arthur L. Reingold and Alan Hubbard

    Citation: BMC Infectious Diseases 2017 17:708

    Published on:

  9. Content type: Research article

    Early HIV diagnosis and initiation onto antiretroviral therapy may prevent ongoing spread of HIV. Risk Tracing Snowball Approach (RTSA) has been shown to be effective in detecting new HIV cases in other settin...

    Authors: Srean Chhim, John Macom, Chettana Pav, Nirada Nim, Phearun Yun, Sopheap Seng, Kolab Chhim, Sovannary Tuot and Siyan Yi

    Citation: BMC Infectious Diseases 2017 17:689

    Published on:

  10. Content type: Research article

    Enterocytozoon bieneusi has been increasingly reported to infect humans and various mammals. Microsporidia cause diarrhea in HIV-infected patients worldwide. PCR amplification and sequ...

    Authors: Hua Liu, Zhihua Jiang, Zhongying Yuan, Jianhai Yin, Zunfu Wang, Bingxue Yu, Dongsheng Zhou, Yujuan Shen and Jianping Cao

    Citation: BMC Infectious Diseases 2017 17:684

    Published on:

  11. Content type: Research article

    Despite young people being a key population for HIV prevention, the HIV epidemic amongst young Brazilians is perceived to be growing. We therefore reviewed all published literature on HIV prevalence and risk f...

    Authors: Igor Pedrosa Saffier, Hélia Kawa and Guy Harling

    Citation: BMC Infectious Diseases 2017 17:675

    Published on:

  12. Content type: Research article

    There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify t...

    Authors: Daniel N. A. Ankrah, Margaret Lartey, Aukje K. Mantel-Teeuwisse and Hubert G. M. Leufkens

    Citation: BMC Infectious Diseases 2017 17:664

    Published on:

  13. Content type: Research article

    Dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) is a simple combination of drugs that has the best genetic barrier to HIV-1 resistance and may be fit for salvage therapy.

    Authors: Amedeo F. Capetti, Maria Vittoria Cossu, Giancarlo Orofino, Gaetana Sterrantino, Giovanni Cenderello, Giuseppe V. De Socio, Anna Maria Cattelan, Alessandro Soria, Stefano Rusconi, Niccolò Riccardi, Gian Maria Baldin, Fosca P. Niero, Giorgio Barbarini and Giuliano Rizzardini

    Citation: BMC Infectious Diseases 2017 17:658

    Published on:

  14. Content type: Research article

    Accurately identifying individuals who are on antiretroviral therapy (ART) is important to determine ART coverage and proportion on ART who are virally suppressed. ART is also included in recent infection test...

    Authors: Helena Huerga, Fisseha Shiferie, Eduard Grebe, Ruggero Giuliani, Jihane Ben Farhat, Gilles Van-Cutsem and Karen Cohen

    Citation: BMC Infectious Diseases 2017 17:653

    Published on:

  15. Content type: Case report

    Hemophagocytic lymphohistiocytosis (HLH) is an uncommon systemic inflammatory condition that can result from infections, autoimmune diseases and malignancies. It is a rarely reported life threatening complicat...

    Authors: Farheen Manji, Evan Wilson, Etienne Mahe, John Gill and John Conly

    Citation: BMC Infectious Diseases 2017 17:633

    Published on:

  16. Content type: Research article

    Dolutegravir (DTG) is metabolized mainly by uridine diphosphate (UDP)-glucuronosyltransferase 1A1 (UGT1A1), and partly by cytochrome P450 3A (CYP3A). Therefore, we focused on UGT1A1 gene polymorphisms (*6 and *28...

    Authors: Hiroki Yagura, Dai Watanabe, Hiroyuki Kushida, Kosuke Tomishima, Hiroaki Togami, Atsushi Hirano, Masaaki Takahashi, Kazuyuki Hirota, Motoko Ikuma, Daisuke Kasai, Yasuharu Nishida, Munehiro Yoshino, Kunio Yamazaki, Tomoko Uehira and Takuma Shirasaka

    Citation: BMC Infectious Diseases 2017 17:622

    Published on:

  17. Content type: Research article

    The clinical care of people living with HIV changed fundamentally as a result of the development of effective antiretroviral therapy (ART). HIV infection is now a long-term treatable condition. We report a nat...

    Authors: A. Molloy, H. Curtis, F. Burns and A. Freedman

    Citation: BMC Infectious Diseases 2017 17:619

    Published on:

  18. Content type: Study protocol

    With potent antiretroviral drugs, HIV infection is becoming a chronic disease. Emergence of comorbidities, particularly cardiovascular disease (CVD) has become a leading concern for patients living with the in...

    Authors: Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, Sylvie Trottier, Benoit Trottier, Marianne Harris, Sharon Walmsley, Brian Conway, Alexander Wong, Jean-Pierre Routy, Colin Kovacs, Paul A. MacPherson, Kenneth Marc Monteith, Samer Mansour, George Thanassoulis, Michal Abrahamowicz…

    Citation: BMC Infectious Diseases 2017 17:611

    Published on:

  19. Content type: Research article

    Little is known regarding the restoration of the specific immune response after combined antiretroviral therapy (cART) and anti-tuberculosis (TB) therapy introduction among TB-HIV patients. In this study, we e...

    Authors: Tatiana Pereira da Silva, Carmem Beatriz Wagner Giacoia-Gripp, Carolina A. Schmaltz, Flavia Marinho Sant’Anna, Maria Helena Saad, Juliana Arruda de Matos, Julio Castro Alves de Lima e Silva, Valeria Cavalcanti Rolla and Mariza Gonçalves Morgado

    Citation: BMC Infectious Diseases 2017 17:606

    Published on:

Previous Page Page 1 of 23 Next Page

2016 Journal Metrics

Advertisement